文献速递脊柱外科

2013和2014财年医疗保险受益人颈椎融合术中不良事件相关的增量住院费用和住院时长

Incremental Hospital Cost and Length-of-stay Associated With Treating Adverse Events Among Medicare Beneficiaries Undergoing Cervical Spinal Fusion During Fiscal Year 2013 and 2014.
PubMed 文献 · Spine (Phila Pa 1976) · 2017-01-01

该回顾性研究利用2013和2014财年Medicare分析文件识别86,265例接受2或3节段颈椎融合术的受益人,用ICD-9-CM编码识别10种不良事件,估算治疗各不良事件的观察及风险调整后增量住院资源。6.2%受益人经历至少一种不良事件,任何并发症增量费用28,638美元、增量住院9.1天;风险调整后增量费用从感染42,358美元至硬膜撕裂10,100美元。

要点

  • 6.2%接受颈椎融合术的Medicare受益人经历至少一种研究定义的不良事件。
  • 任何并发症增量费用为28,638美元,增量住院时长为9.1天。
  • 风险调整后增量费用从感染42,358美元至硬膜撕裂10,100美元。

核心结论

  • 不良事件在颈椎融合术患者中经常发生,并大幅增加住院费用。
  • 共享决策工具应在手术考虑前向患者明确提供这些风险估计。
  • 投资于已被证明可减少特定不良事件的活动是有依据的,本研究或可帮助卫生系统确定绩效改进领域的优先次序。

研究设计与样本

  • 回顾性研究,使用2013和2014财年Medicare提供者分析与审查文件识别86,265例接受2或3节段颈椎融合术的受益人。
  • 使用国际疾病分类第9版临床修订版诊断和操作编码识别10种不良事件,估算观察及风险调整后增量住院资源(费用[2014年美元]和住院时长)。

主要发现

  • 总体6.2%接受颈椎融合术的受益人经历至少一种研究定义的不良事件。
  • 经历任何并发症的受益人消耗显著更多住院资源,增量费用为28,638美元,增量住院时长为9.1天。
  • 调整患者人口学和合并症后,治疗不良事件的增量费用从感染42,358美元至硬膜撕裂10,100美元。

临床怎么用

  • 作者认为共享决策工具应在手术考虑前向患者明确提供这些风险估计。
  • 作者认为投资于已被证明可减少特定不良事件的活动是有依据的,本研究或可帮助卫生系统确定绩效改进领域的优先次序。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY DESIGN: A retrospective study. OBJECTIVE: To report the incremental hospital resources consumed with treating adverse events experienced by Medicare beneficiaries undergoing a two or three vertebrae level cervical spinal fusion. SUMMARY OF BACKGROUND DATA: Hospitals are increasingly at financial risk for patients experiencing adverse events due "pay for performance." Little is known about incremental resources consumed when treating patients who experienced an adverse event after cervical spinal fusions. METHODS: Fiscal years 2013 and 2014 Medicare Provider Analysis and Review file was used to identify 86,265 beneficiaries who underwent 2 or 3 vertebrae level cervical spinal fusion. International Classification of Diseases 9th Clinical Modification diagnostic and procedure codes were used to identify 10 adverse events. This study estimated both the observed and risk-adjusted incremental hospital resources consumed (cost [2014 US $] and length-of-stay) in treating beneficiaries experiencing each adverse event. RESULTS: Overall, 6.2% of beneficiaries undergoing cervical spinal fusion experienced at least one of the study's adverse events. Beneficiaries experiencing any complication consumed significantly more hospital resources (incremental cost of $28,638) and had longer length-of-stay (incremental stays of 9.1 days). After adjusting for patient demographics and comorbid conditions, incremental cost of treating adverse events ranged from $42,358 (infection) to $10,100 (dural tear). CONCLUSION: Adverse events frequently occur and add substantially to the hospital costs of patients undergoing cervical spinal fusion. Shared decision-making instruments should clearly provide these risk estimates to the patient before surgical consideration. Investment in activities that have been shown to reduce specific adverse events is warranted, and this study may allow health systems to prioritize performance improvement areas. LEVEL OF EVIDENCE: 3.

来源:Spine (Phila Pa 1976),查看原文。版权归原作者所有。

引用

  1. Culler SD, McGuire KJ, Little KM, et al. Incremental Hospital Cost and Length-of-stay Associated With Treating Adverse Events Among Medicare Beneficiaries Undergoing Cervical Spinal Fusion During Fiscal Year 2013 and 2014. Spine (Phila Pa 1976). 2017. PMID: 28591072. doi:10.1097/BRS.0000000000002268

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。